Hugel, Inc. (KOSDAQ:145020)
235,000
-7,000 (-2.89%)
At close: Jan 19, 2026
Hugel Market Cap
Hugel has a market cap or net worth of 2.54 trillion as of January 16, 2026. Its market cap has decreased by -14.48% in one year.
Market Cap
2.54T
Enterprise Value
2.12T
Revenue
404.19B
Ranking
n/a
PE Ratio
18.46
Stock Price
235,000.00
Market Cap Chart
Since December 24, 2015, Hugel's market cap has increased from 552.70B to 2.54T, an increase of 359.25%. That is a compound annual growth rate of 16.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 2.61T | 4.99% |
| Dec 30, 2025 | 2.49T | -19.40% |
| Dec 30, 2024 | 3.09T | 84.38% |
| Dec 28, 2023 | 1.68T | 4.84% |
| Dec 29, 2022 | 1.60T | -14.29% |
| Dec 30, 2021 | 1.86T | -20.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 27.70T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.43T |
| Yuhan | 8.05T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |